1. Home
  2. A vs MDLN Comparison

A vs MDLN Comparison

Compare A & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agilent Technologies Inc.

A

Agilent Technologies Inc.

N/A

Current Price

$178.05

Market Cap

38.0B

Sector

Industrials

ML Signal

N/A

Logo Medline Inc. Class A Common Stock

MDLN

Medline Inc. Class A Common Stock

N/A

Current Price

$42.20

Market Cap

30.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
A
MDLN
Founded
1999
1966
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.0B
30.7B
IPO Year
1999
2025

Fundamental Metrics

Financial Performance
Metric
A
MDLN
Price
$178.05
$42.20
Analyst Decision
Buy
Buy
Analyst Count
22
27
Target Price
★ $182.05
$45.31
AVG Volume (30 Days)
1.6M
★ 9.8M
Earning Date
11-23-2026
11-04-2026
Dividend Yield
★ 0.57%
N/A
EPS Growth
★ 3.16
N/A
EPS
★ 3.55
0.45
Revenue
$4,472,000,000.00
★ $28,432,000,000.00
Revenue This Year
$7.94
$10.44
Revenue Next Year
$6.42
$8.03
P/E Ratio
★ $50.30
$91.29
Revenue Growth
6.43
★ 11.47
52 Week Low
$108.35
$31.37
52 Week High
$182.99
$50.88

Technical Indicators

Market Signals
Indicator
A
MDLN
Relative Strength Index (RSI) 56.40 75.32
Support Level $169.59 $40.90
Resistance Level $182.99 $43.31
Average True Range (ATR) 4.98 1.59
MACD -0.34 0.88
Stochastic Oscillator 64.31 95.51

Price Performance

Historical Comparison
A
MDLN

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

About MDLN Medline Inc. Class A Common Stock

Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.

Share on Social Networks: